Loading
Latest filing published 30 Dec 2025 for Kairos Pharma, LTD.. Read the official filing
No signal scores available.
All filings by Neil Bhowmick on record concern Kairos Pharma, Ltd. In total, 2 filings cover trades dated from 1 January 2025 to 8 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 30 December 2025, the filings show a share grant in Kairos Pharma, Ltd. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations